Skip to search.
 TSX Up 2.88% TSX Ventures Up 2.99%

Nektar Therapeutics (NKTR)

-NasdaqGS
10.83 Up 0.75(7.44%) Aug 27, 4:00PM EDT
|After Hours : 10.83 0.00 (0.00%) Aug 27, 4:43PM EDT
Add to Portfolio
Prev Close:10.08
Open:10.17
Bid:10.00 x 100
Ask:12.99 x 100
1y Target Est:16.80
Beta:0.941442
Earnings Date:Nov 4 - Nov 9 (Est.)
Day's Range:10.10 - 10.85
52wk Range:9.16 - 17.53
Volume:1,859,263
Avg Vol (3m):1,686,820
Market Cap:1.43B
P/E (ttm):230.43
EPS (ttm):0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NKTRUp 7.44%1.43B
GSKUp 1.83%99.60B
BMYUp 1.32%101.42B
ENZNUp 9.28%46.83M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.59
Quarterly EPS Est (Sep-15) :-0.28
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):2.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback